|
1
|
Gevers TJ and Drenth JP: Diagnosis and
management of polycystic liver disease. Nat Rev Gastroenterol
Hepatol. 10:101–108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Que F, Nagorney DM, Gross JB Jr and Torres
VE: Liver resection and cyst fenestration in the treatment of
severe polycystic liver disease. Gastroenterology. 108:487–494.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoshino J, Ubara Y, Suwabe T, Sumida K,
Hayami N, Mise K, Hiramatsu R, Hasegawa E, Yamanouchi M, Sawa N, et
al: Intravascular embolization therapy in patients with enlarged
polycystic liver. Am J Kidney Dis. 63:937–944. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Temmerman F, Ho TA, Vanslembrouck R,
Coudyzer W, Billen J, Dobbels F, van Pelt J, Bammens B, Pirson Y
and Nevens F: Lanreotide reduces liver volume, but might not
improve muscle wasting or weight loss, in patients with symptomatic
polycystic liver disease. Clin Gastroenterol Hepatol.
13:2353–2359.e2351. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aussilhou B, Douflé G, Hubert C, Francoz
C, Paugam C, Paradis V, Farges O, Vilgrain V, Durand F and Belghiti
J: Extended liver resection for polycystic liver disease can
challenge liver transplantation. Ann Surg. 252:735–743. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Drenth JP, Chrispijn M, Nagorney DM,
Kamath PS and Torres VE: Medical and surgical treatment options for
polycystic liver disease. Hepatology. 52:2223–2230. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qian Q: Isolated polycystic liver disease.
Adv Chronic kidney Dis. 17:181–189. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gigot JF, Jadoul P, Que F, Van Beers BE,
Etienne J, Horsmans Y, Collard A, Geubel A, Pringot J and Kestens
PJ: Adult polycystic liver disease: Is fenestration the most
adequate operation for long-term management? Ann Surg. 225:286–294.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pugh RN, Murray-Lyon IM, Dawson JL,
Pietroni MC and Williams R: Transection of the oesophagus for
bleeding oesophageal varices. Br J Surg. 60:646–649. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Child CG and Turcotte JG: Surgery and
portal hypertension. Major Probl Clin Surg. 1:1–85. 1964.PubMed/NCBI
|
|
11
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the eastern cooperative oncology group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Clavien PA, Barkun J, de Oliveira ML,
Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J,
Slankamenac K, Bassi C, et al: The Clavien-Dindo classification of
surgical complications: Five-year experience. Ann Surg.
250:187–196. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li A, Davila S, Furu L, Qian Q, Tian X,
Kamath PS, King BF, Torres VE and Somlo S: Mutations in PRKCSH
cause isolated autosomal dominant polycystic liver disease. Am J
Hum Genet. 72:691–703. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Drenth JP, te Morsche RH, Smink R,
Bonifacino JS and Jansen JB: Germline mutations in PRKCSH are
associated with autosomal dominant polycystic liver disease. Nat
Genet. 33:345–347. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Davila S, Furu L, Gharavi AG, Tian X, Onoe
T, Qian Q, Li A, Cai Y, Kamath PS, King BF, et al: Mutations in
SEC63 cause autosomal dominant polycystic liver disease. Nat Genet.
36:575–577. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cnossen WR, te Morsche RH, Hoischen A,
Gilissen C, Chrispijn M, Venselaar H, Mehdi S, Bergmann C, Veltman
JA and Drenth JP: Whole-exome sequencing reveals LRP5 mutations and
canonical Wnt signaling associated with hepatic cystogenesis. Proc
Natl Acad Sci USA. 111:5343–5348. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Perugorria MJ, Masyuk TV, Marin JJ,
Marzioni M, Bujanda L, LaRusso NF and Banales JM: Polycystic liver
diseases: Advanced insights into the molecular mechanisms. Nat Rev
Gastroenterol Hepatol. 11:750–761. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rossetti S, Consugar MB, Chapman AB,
Torres VE, Guay-Woodford LM, Grantham JJ, Bennett WM, Meyers CM,
Walker DL, Bae K, et al: Comprehensive molecular diagnostics in
autosomal dominant polycystic kidney disease. J Am Soc Nephrol.
18:2143–2160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ward CJ, Hogan MC, Rossetti S, Walker D,
Sneddon T, Wang X, Kubly V, Cunningham JM, Bacallao R, Ishibashi M,
et al: The gene mutated in autosomal recessive polycystic kidney
disease encodes a large, receptor-like protein. Nat Genet.
30:259–269. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wills ES, Roepman R and Drenth JP:
Polycystic liver disease: Ductal plate malformation and the primary
cilium. Trends Mol Med. 20:261–270. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Everson GT, Taylor MR and Doctor RB:
Polycystic disease of the liver. Hepatology. 40:774–782. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Swenson K, Seu P, Kinkhabwala M, Maggard
M, Martin P, Goss J and Busuttil R: Liver transplantation for adult
polycystic liver disease. Hepatology. 28:412–415. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alvaro D, Barbaro B, Franchitto A, Onori
P, Glaser SS, Alpini G, Francis H, Marucci L, Sterpetti P,
Ginanni-Corradini S, et al: Estrogens and insulin-like growth
factor 1 modulate neoplastic cell growth in human
cholangiocarcinoma. Am J Pathol. 169:877–888. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chapman AB: Cystic disease in women:
Clinical characteristics and medical management. Adv Ren Replace
Ther. 10:24–30. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bae KT, Zhu F, Chapman AB, Torres VE,
Grantham JJ, Guay-Woodford LM, Baumgarten DA, King BF Jr, Wetzel
LH, Kenney PJ, et al: Magnetic resonance imaging evaluation of
hepatic cysts in early autosomal-dominant polycystic kidney
disease: The consortium for radiologic imaging studies of
polycystic kidney disease cohort. Clin J Am Soc Nephrol. 1:64–69.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rajoriya N, Tripathi D, Leithead JA,
Gunson BK, Lord S, Ferguson JW and Hirschfield GM: Portal
hypertension in polycystic liver disease patients does not affect
wait-list or immediate post-liver transplantation outcomes. World J
Gastroenterol. 22:9966–9973. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Barbier L, Ronot M, Aussilhou B, Cauchy F,
Francoz C, Vilgrain V, Soubrane O, Paradis V and Belghiti J:
Polycystic liver disease: Hepatic venous outflow obstruction
lesions of the non-cystic parenchyma have major consequences.
Hepatology. 68:652–662. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dumont PN, Rode A, Mabrut JY, Ducerf C and
Golse N: Polycystic liver disease complicated by obstructive
jaundice. J Visc Surg. 153:149–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Temmerman F, Dobbels F, Ho TA, Pirson Y,
Vanslembrouck R, Coudyzer W, Bammens B, van Pelt J, Pirenne J and
Nevens F: Development and validation of a polycystic liver disease
complaint-specific assessment (POLCA). J Hepatol. 61:1143–1150.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sherstha R, McKinley C, Russ P,
Scherzinger A, Bronner T, Showalter R and Everson GT:
Postmenopausal estrogen therapy selectively stimulates hepatic
enlargement in women with autosomal dominant polycystic kidney
disease. Hepatology. 26:1282–1286. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hogan MC, Masyuk TV, Page LJ, Kubly VJ,
Bergstralh EJ, Li X, Kim B, King BF, Glockner J, Holmes DR, et al:
Randomized clinical trial of long-acting somatostatin for autosomal
dominant polycystic kidney and liver disease. J Am Soc Nephrol.
21:1052–1061. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
van Keimpema L, Nevens F, Vanslembrouck R,
van Oijen MG, Hoffmann AL, Dekker HM, de Man RA and Drenth JP:
Lanreotide reduces the volume of polycystic liver: A randomized,
double-blind, placebo-controlled trial. Gastroenterology.
137:1661–1668.e1661-1662. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
D'Agnolo HM, Kievit W, Takkenberg RB,
Riaño I, Bujanda L, Neijenhuis MK, Brunenberg EJ, Beuers U, Banales
JM and Drenth JP: Ursodeoxycholic acid in advanced polycystic liver
disease: A phase 2 multicenter randomized controlled trial. J
Hepatol. 65:601–607. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qian Q, Du H, King BF, Kumar S, Dean PG,
Cosio FG and Torres VE: Sirolimus reduces polycystic liver volume
in ADPKD patients. J Am Soc Nephrol. 19:631–638. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chrispijn M, Nevens F, Gevers TJ,
Vanslembrouck R, van Oijen MG, Coudyzer W, Hoffmann AL, Dekker HM,
de Man RA, van Keimpema L and Drenth JP: The long-term outcome of
patients with polycystic liver disease treated with lanreotide.
Aliment Pharmacol Ther. 35:266–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Baber JT, Hiatt JR, Busuttil RW and
Agopian VG: A 20-year experience with liver transplantation for
polycystic liver disease: Does previous palliative surgical
intervention affect outcomes? J Am Coll Surg. 219:695–703. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Temmerman F, Missiaen L, Bammens B,
Laleman W, Cassiman D, Verslype C, van Pelt J and Nevens F:
Systematic review: The pathophysiology and management of polycystic
liver disease. Aliment Pharmacol Ther. 34:702–713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Eason JD, Gonwa TA, Davis CL, Sung RS,
Gerber D and Bloom RD: Proceedings of consensus conference on
simultaneous liver kidney transplantation (SLK). Am J Transplant.
8:2243–2251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Coquillard C, Berger J, Daily M, Shah M,
Mei X, Marti F and Gedaly R: Combined liver-kidney transplantation
for polycystic liver and kidney disease: Analysis from the United
Network for Organ Sharing dataset. Liver Int. 36:1018–1025. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kwok MK and Lewin KJ: Massive hepatomegaly
in adult polycystic liver disease. Am J Surg Pathol. 12:321–324.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Starzl TE, Reyes J, Tzakis A, Mieles L,
Todo S and Gordon R: Liver transplantation for polycystic liver
disease. Arch Surg. 125:575–577. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gedaly R, Guidry P, Davenport D, Daily M,
Ronsenau J, Shah M, Cooper MA and Hundley J: Peri-operative
challenges and long-term outcomes in liver transplantation for
polycystic liver disease. HPB (Oxford). 15:302–306. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zamora-Valdés D, Contreras AG and Mercado
MA: Liver transplantation for polycystic liver disease. J Am Coll
Surg. 219:11922014. View Article : Google Scholar
|
|
44
|
van Keimpema L, Nevens F, Adam R, Porte
RJ, Fikatas P, Becker T, Kirkegaard P, Metselaar HJ, Drenth JP,
European Liver and Intestine Transplant Association: Excellent
survival after liver transplantation for isolated polycystic liver
disease: An European Liver Transplant Registry study. Transpl Int.
24:1239–1245. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Arrazola L, Moonka D, Gish RG and Everson
GT: Model for end-stage liver disease (MELD) exception for
polycystic liver disease. Liver Transpl 12 (12 Suppl). S110–S111.
2006. View Article : Google Scholar
|
